1. Fatal pulmonary embolism due to ınherited thrombophilia factors in a child with wolfram syndrome
- Author
-
Kucuktasci, K., Semiz, Serap, Balcı, Yasemin Işık, Özsari, T., Gürses, Dolunay, Önem, Gökhan, Saçar, Mustafa, Düzcan, Füsun, Yüksel, Doğangün, and Semiz, Ender
- Subjects
desmopressin ,pulmonary embolism ,loading drug dose ,resuscitation ,heparin ,thrombofilia risk factors ,physical examination ,protein C ,rheumatoid factor ,computer assisted tomography ,diabetic ketoacidosis ,Fatal Outcome ,methylenetetrahydrofolate reductase gene ,echocardiography ,Thrombophilia ,genetics ,gene mutation ,C reactive protein ,heart atrium thrombosis ,single drug dose ,enoxaparin ,optic nerve atrophy ,blood clotting factor 5 ,female ,priority journal ,risk factor ,diabetes insipidus ,thrombectomy ,laboratory test ,diabetes mellitus ,activated protein C resistance ,lung embolism ,insulin ,cardiopulmonary arrest ,Adolescent ,methylenetetrahydrofolate reductase (NADPH2) ,complication ,embolism ,insulin dependent diabetes mellitus ,Article ,clinical examination ,fatality ,case report ,degenerative disease ,heterozygosity ,Humans ,human ,gene ,thrombosis ,Wolfram syndrome ,Glasgow coma scale ,Factor V ,hearing impairment ,thromboembolism ,ceftriaxone ,warfarin ,blood clotting factor 5 Leiden ,Diabetes Mellitus, Type 1 ,homozygosity - Abstract
Wolfram syndrome-1 is a rare and severe autosomal recessive neurodegenerative disease characterized by diabetes mellitus (DM), optic atrophy, diabetes insipidus, and deafness. Poorly controlled type 1 DM increases the risk for thrombosis. However, coexistence of DM and hereditary thrombosis factors is rarely observed. Here we present the case of a 13.5-year-old, nonfollowed girl newly diagnosed with poorly controlled Wolfram syndrome on the basis of the results of clinical and laboratory examinations. On the eighth day after diabetic ketoacidosis treatment, pulmonary embolism developed in the subject. Thrombus identified in the right atrium using echocardiography was treated by emergency thrombectomy. Homozygous mutation in the methylenetetrahydrofolate reductase gene C677T, heterozygous factor-V Leiden mutation, and active protein C resistance were identified in the patient. The patient was lost because of a recurring episode of pulmonary embolism on the 86th day of hospitalization. We present this case to highlight the need for investigating hereditary thrombosis risk factors in diabetic patients in whom thromboembolism develops. Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.
- Published
- 2016